Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
2Flo Ventures is an early-stage venture capital firm and startup studio investing in healthcare innovation with a strong focus on health equity. Its portfolio spans biotechnology, medical devices, digital health solutions, regenerative medicine, immunotherapies for autoimmune disease and cancer, nanoparticle therapies for shock states, precision oncology platforms for early cancer detection/prevention across populations—including underserved communities—and cannabinoid-based pain relief. Portfolio companies have collectively raised over $85 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 2Flo Ventures.